On sample size calculation for comparing survival curves under general hypothesis testing. Read more about On sample size calculation for comparing survival curves under general hypothesis testing.
Phase II cancer clinical trials with heterogeneous patient populations. Read more about Phase II cancer clinical trials with heterogeneous patient populations.
Variable selection for optimal treatment decision. Read more about Variable selection for optimal treatment decision.
Marginal hazard regression for correlated failure time data with auxiliary covariates. Read more about Marginal hazard regression for correlated failure time data with auxiliary covariates.
Sample size and power determination in joint modeling of longitudinal and survival data. Read more about Sample size and power determination in joint modeling of longitudinal and survival data.
Additive mixed effect model for clustered failure time data. Read more about Additive mixed effect model for clustered failure time data.
Multiple testing of treatment-effect-modifying biomarkers in a randomized clinical trial with a survival endpoint. Read more about Multiple testing of treatment-effect-modifying biomarkers in a randomized clinical trial with a survival endpoint.
Semiparametric inference for a 2-stage outcome-auxiliary-dependent sampling design with continuous outcome. Read more about Semiparametric inference for a 2-stage outcome-auxiliary-dependent sampling design with continuous outcome.
Clinical trials data collection: when less is more. Read more about Clinical trials data collection: when less is more.